| Literature DB >> 34940229 |
Yue Wang1, Yu Huang1, Hongyi Bai2, Guoqing Wang3, Xuehao Hu4, Santosh Kumar5, Rui Min1.
Abstract
This article discusses recent advances in biocompatible and biodegradable polymer optical fiber (POF) for medical applications. First, the POF material and its optical properties are summarized. Then, several common optical fiber fabrication methods are thoroughly discussed. Following that, clinical applications of biocompatible and biodegradable POFs are discussed, including optogenetics, biosensing, drug delivery, and neural recording. Following that, biomedical applications expanded the specific functionalization of the material or fiber design. Different research or clinical applications necessitate the use of different equipment to achieve the desired results. Finally, the difficulty of implanting flexible fiber varies with its flexibility. We present our article in a clear and logical manner that will be useful to researchers seeking a broad perspective on the proposed topic. Overall, the content provides a comprehensive overview of biocompatible and biodegradable POFs, including previous breakthroughs, as well as recent advancements. Biodegradable optical fibers have numerous applications, opening up new avenues in biomedicine.Entities:
Keywords: biocompatible; biodegradable; biomedical application; polymer optical fiber
Mesh:
Substances:
Year: 2021 PMID: 34940229 PMCID: PMC8699361 DOI: 10.3390/bios11120472
Source DB: PubMed Journal: Biosensors (Basel) ISSN: 2079-6374
Figure 1A summary of this review about biocompatible and biodegradable polymer optical fibers.
Classification of biocompatible polymer optical fiber.
| Subchapter | Category | Material |
|---|---|---|
| 2.1 | Natural materials | Silk |
| 2.2 | Hydrogel | PEG 1 |
| 2.3 | Synthetic | PLA 4, PGA 5, PLGA 6 |
| 2.4 | Elastomers | PDMS 8 |
| 2.5 | Multifunctional | PC 10, COC 11, CPE 12 |
1 Poly (ethylene glycol). 2 Poly (ethylene glycol) diacrylate. 3 Polyacrylamide. 4 Poly (lactic acid). 5 Poly (glycolic acid). 6 Poly (lactic-co-glycolic acid). 7 Poly (L-lactic acid). 8 olydimethylsiloxane. 9 Poly (octamethylene citrate)-poly (octamethylene maleate citrate). 10 Polycarbonate. 11 Cyclic olefin copolymer. 12 Conductive polyethylene.
Figure 2Chemical formula of PEGDA.
Main characteristics of the hydrogel materials.
| Name | Characteristics | Ref. |
|---|---|---|
| PEG | Colorless viscous liquid | [ |
| PEGDA | Hydrophilic and elastic hydrogel | [ |
| AAm | White powder | [ |
Main characteristics of the synthetic polymer materials.
| Name | Characteristics | Ref. |
|---|---|---|
| PLA | Density: 1.25–1.28 g/mL | [ |
| PGA | Crystallinity degree: 45–55% | [ |
| PLGA | Crystallinity degree: 45–55% | [ |
| PLLA | Flexural strength: 48–110 MPa | [ |
Main characteristics of the elastomer materials.
| Name | Characteristics | Ref. |
|---|---|---|
| PDMS | Colorless | [ |
| Citric acid | Density: 1.542 g/cm3 | [ |
| 1,8-octanediol | Melting point: 57 °C–61 °C | [ |
| Maleic anhydrate | Melting point:51 °C–54 °C | [ |
Preparation methods of preform constituents of multifunctional fiber.
| Metal | Semiconductor | Polymer |
|---|---|---|
| Milling | Evaporation | Casting |
Figure 3(a) A schematic of the thermal drawing process. (Adapted from ref. [132]). (b) A schematic of the preform fabrication process of design I. (Adapted from ref. [55]). (c) A cross-sectional optical image of design I, which has one cylindrical waveguide, two electrodes, and two microfluidic channels. (Reprinted with permission from ref. [40]). (d) A cross-sectional optical image of design II, which has one surrounding waveguide, four electrodes, and one microfluidic channel. (Reprinted with permission from ref. [40]).
Figure 4(a) A schematic of the simplified thermal drawing process of the PLLA-based optical fiber. (Adapted from ref. [45]). (b) A schematic of the horizontal thermal drawing process of TPE-based fiber. (Reprinted with permission from ref. [133]).
Figure 5(a) A schematic showing the extrusion process. (Adapted with permission from ref. [56]). (b) A schematic showing the extrusion-based 3D printing. (Adapted with permission from ref. [56]).
Figure 6A schematic showing the (a) ILDAWS process. (Reprinted with permission from ref. [88]). (b) Bioinspired dry spinning process. (Reprinted with permission from ref. [140]). (c) Vertical electrospinning setup device. (Adapted from ref. [148]). (d) Horizontal electrospinning setup device. (Adapted from ref. [148]).
Summary of biocompatible optical fiber probes fabricated via spinning, including main materials, brief introduction of the fabrication process, properties of obtained fibers, and their corresponding references.
| Materials | Fabrication Methods | Fabrication Process | Properties of Fibers | Ref. |
|---|---|---|---|---|
| PEGDA, AAm, Na-alginate, CaCl2 | Dynamic wet spinning | Preparing the core and sheath spinning solutions and extruding into a coagulation bath, illuminating by 360 nm UV light | Optical attenuation of 0.18 ± 0.01 dB/cm at 650 nm; Young’s modulus < 2.6 MPa | [ |
| Silk, jute fibers | Microfluidic wet spinning | Preparing RSF solution, CNF suspension, and RSF/CNF suspensions, extruding the precursor to a bath containing 95 vol% ethanol aqueous solution | Optical attenuation of 0.1 dB/cm; breaking strength of 710.2 ± 33.2 MPa | [ |
Figure 7(a) A schematic showing the fabrication process of casting. (Reprinted with permission from ref. [46]). (b) Images of the obtained p(AM-co-PEGDA-co-3-APBA) based optical fiber. (Reprinted with permission from ref. [46]).
Summary of optical fiber probes fabricated via casting, including main materials, brief introduction of the fabrication process, properties of obtained fibers, and their corresponding references.
| Materials | Fabrication Process | Properties of Fibers | Ref. |
|---|---|---|---|
| PLA and PLGA | Melting the powders, pressing and annealing the melts into films, and laser cutting films into fibers | Planar waveguide; attenuation of 1.6 dB/cm at 635 nm | [ |
| PEGDA, AM and 3-APBA | Casting the precursor solution into a mold to form the core and immersing the core in Na alginate and CaCl2 solution to form the cladding | Glucose-sensitive probe; | [ |
| PEGDA, AM, 3-APBA and N, N′-methylenebisacrylamide | Preparing the precursor, machining the asymmetry microlens array, blending the 3-(acrylamido)phenylboronic acid, and attaching the prepared hydrogel sensor to the fiber’s tip | Glucose-sensitive probe; | [ |
| Silk fibroin and silk hydrogel | Casting the silk solution (silk film) into a mold and dip-coating the core in silk hydrogel (silk hydrogel | Step-index optical finer; | [ |
| Spider silk protein and silkworm silk protein | Dissolving the spider silk protein in hexafluoro-2-propanol at 37 °C for a night and casting the silkworm silk solution in a tube, heating the molds filled with protein solutions at 60 °C for seven days | Biodegradable optical fiber; optical attenuation of 0.8 dB/cm st 635 nm | [ |
| PEG and sodium alginate | Preparing the PEG precursor and injecting it into a tube, illuminating the tube by UV light, coating the core by dipping it in a sodium alginate and calcium chloride | Step-index waveguide; optical attenuation of 0.42 dB/cm at 492 nm | [ |
| PAAm hydrogel and Ca2+ with Na alginate | Preparing the acrylamide with Na alginate precursor, injecting the solution to a tube mold, and illuminating the tube by UV at 50 °C for 30 min | Unclad strain sensing optical fiber; optical attenuation of 0.56 dB/cm at 532 nm | [ |
| Agarose | Boiling the agar and pouring it into a glass mold, | Core-cladding fiber probe; optical attenuation of 3.32 dB/cm at 633 nm | [ |
Several typical polymeric biocompatible optical fibers and their properties.
| Optical Fiber | Attenuation (dB/cm) | Refractive Index | Young’s Modulus | Stretchability (%) | Lifespan | Ref. |
|---|---|---|---|---|---|---|
| Silkworm silk | 0.22 | 1.54–1.55 | 5–12 GPa | 4–16 | n.r. a | [ |
| Spider silk | 0.7–10.5 | 1.5–1.7 | 1–24 GPa | 4–33 | 2–3 weeks | [ |
| Cellulose | 1–2 | 1.475 | n.r. a | 30–70 | ≥90 days | [ |
| PEG hydrogel | 1–6 | 1.35–1.47 | 1–44 kPa | 300–2000 | n.r. a | [ |
| PDMS | 1.8 | 1.41–1.47 | 0.6–2.6 MPa | 95–140 | n.r. a | [ |
| PLLA | 1.5–1.6 | 1.46–1.47 | 2.7–7 GPa | 3–100 | 12–18 weeks | [ |
| PDLLA | 0.11 | n.r. a | n.r. a | 3–10 | 11–15 weeks | [ |
| PLGA (50/50) | n.r. a | 1.47–1.6 | 0.7–7 GPa | 7–20 | 1–25 weeks | [ |
| POC and POMC | 0.4–2 | 1.5–1.54 | 4.7–6 MPa | 50–100 | 4–6 weeks | [ |
a not reported.
Figure 8(a) An example of photodynamic therapy. (Reprinted with permission from ref. [55]). (b) Side view of light delivery using the citrate-based fiber, with the POC cladding and POMC core using a two-step fabrication method. (Reprinted with permission from ref. [67]).
Figure 9A fiber implanted into a freely behaving mouse. (Reprinted with permission from ref. [55]).
Figure 10(a) A fluorescent image of the hydrogel fiber (scale bar = 500 µm) and the inset image is the fiber cross-section (scale bar = 250 µm). (Reprinted with permission from ref. [46]). (b) The calibration curve of the UCNPs-HOF fiber detecting DA in the range of 0–200 μM, and the inset shows a linear plot in a small range (0–1 μM). (Reprinted with permission from ref. [193]).
Figure 11The figure shows the neural activity evoked by optical stimulation delivered through the PC/COC fiber (or COCE fiber) and recorded with the concentric AgNW mesh electrodes in a spinal cord of a Thy1-ChR2-YFP mouse. (Reprinted with permission from ref. [118]).